Skip to content

Short Term Evaluation of the Soothing and Re-epithelizing Activity of Three Topical Products and Relative Combinations

Short Term Evaluation of the Soothing and Re-epithelizing Activity of Three Topical Products and Relative Combinations

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02241161
Enrollment
20
Registered
2014-09-16
Start date
2013-12-31
Completion date
2013-12-31
Last updated
2014-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

skin eythema, rejuvenating cream, rejuvenating serum, antioxidant serum

Brief summary

Aim of the study was to evaluate the soothing and re-epithelizing activity of a single application of topical products on experimentally induced erythema by skin stripping on the forearm (volar surface) of 20 healthy volunteers. In particular the activity of the following three cosmetic products and the relative combinations (cream and serum) were assessed: rejuvenating cream, rejuvenating serum, antioxidant serum

Interventions

OTHERplantaricin a - rejuvenating cream

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

OTHERplantaricin a - antioxidant serum

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

OTHERplantaricin a - rejuvenating serum

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

Sponsors

Derming SRL
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult volunteers of both sexes, aged more than 18 years old * Volunteers in a good general state of health in the Investigator opinion * Volunteers not taking drugs or undergoing surgical procedure * Volunteers who are giving a written informed consent.

Exclusion criteria

* Pregnancy (only for female subjects) * lactation (only for female subjects) * change in the normal habits in the last month * participation in a similar study during the previous month * known allergy to one or several ingredients of the products on trial * insufficient adhesion to the study protocol * dermatological disease * clinical and significant skin condition on the test area (e.g. lesions, scars, malformations) * diabetes * endocrine disease * hepatic, renal or cardiac disorder * cancer * topical drugs or surgical procedure on the test areas during the previous 3 months * systemic corticosteroids * aspirin or non-steroid anti-inflammatory drugs (FANS) * diuretic drugs * antibiotics and chemotherapics * pshycotropic drugs * retinoids * psoralens * cardiologic and vascular drugs

Design outcomes

Primary

MeasureTime frameDescription
Clinical evaluation of skin erythema: change from baseline, 1 hour after products application (T1h vs. T0)After 1 (T1h) hour from products applicationSkin erythema was scored and recorded according to the following grades: 0=no erythema; 0.5=very slight erythema (barely perceptible);1=well-defined erythema;1.5=moderate to severe erythema; 2=severe erythema (beet redness) to slight eschar formation (injuries in depth)

Secondary

MeasureTime frameDescription
Clinical evaluation of skin erythema: change from baseline, after 24 hours from products application (T24h vs. T0)After 24 (T24h) hours from products applicationSkin erythema was scored and recorded according to the following grades: 0=no erythema; 0.5=very slight erythema (barely perceptible);1=well-defined erythema;1.5=moderate to severe erythema; 2=severe erythema (beet redness) to slight eschar formation (injuries in depth)
Optical densitometry: change from baseline, after 1hour from products application (T1h vs. T0)After 1 (T1h) hour from products applicationThe instrumental measurement of erythema was performed by the use of an optical densitometer allowing to quantify, on a logarithmic scale, total reflected optical density (visual=V) and the values of primary subtractive colours of reflected light: cyan(=C), magenta(=M) and yellow(=Y). Calculation of erythema index was done as follows: E.I.=logRmagenta-logRcyan
Optical densitometry: change from baseline, 6 hours from products application (T6h vs. T0)After 6 (T6h) hours from products applicationThe instrumental measurement of erythema was performed by the use of an optical densitometer allowing to quantify, on a logarithmic scale, total reflected optical density (visual=V) and the values of primary subtractive colours of reflected light: cyan(=C), magenta(=M) and yellow(=Y). Calculation of erythema index was done as follows: E.I.=logRmagenta-logRcyan
Clinical evaluation of skin erythema: change from baseline, 6 hours from products application (T6h vs. T0)After 6 (T6h) hours from products applicationSkin erythema was scored and recorded according to the following grades: 0=no erythema; 0.5=very slight erythema (barely perceptible);1=well-defined erythema;1.5=moderate to severe erythema; 2=severe erythema (beet redness) to slight eschar formation (injuries in depth)
Surface microrelief evaluation: change from baseline, after 1 hour from products application (T1h vs.T0)After 1 (Th1) hour from products applicationMorfometrical analysis of cutaneous surface allows the evaluation of the regularity of the microrelief (superficial cutaneous network). It was therefore possible to determinate the alteration of the microrelief caused by stripping.The evaluation of the regularity grade of cutaneous microrelief was possible using Fast Fourier Transform (FFT) on skin replicas obtained using silicone rubber. Skin replicas images were then acquired by a stereo microscope.
Surface microrelief evaluation: change from baseline, 6 hours from products application (T6h vs. T0)After 6 (T6h) hours from products applicationMorfometrical analysis of cutaneous surface allows the evaluation of the regularity of the microrelief (superficial cutaneous network). It was therefore possible to determinate the alteration of the microrelief caused by stripping.The evaluation of the regularity grade of cutaneous microrelief was possible using Fast Fourier Transform (FFT) on skin replicas obtained using silicone rubber. Skin replicas images were then acquired by a stereo microscope.
Surface microrelief evaluation: change from baseline, after 24 hours from products application (T24h) hours from products application vs.T0)After 24 hours (T24h) from products applicationMorfometrical analysis of cutaneous surface allows the evaluation of the regularity of the microrelief (superficial cutaneous network). It was therefore possible to determinate the alteration of the microrelief caused by stripping.The evaluation of the regularity grade of cutaneous microrelief was possible using Fast Fourier Transform (FFT) on skin replicas obtained using silicone rubber. Skin replicas images were then acquired by a stereo microscope.
Optical densitometry: change from baseline, 24 hours from products application (T24h vs.T0)After 24 (T24h) hours from products applicationThe instrumental measurement of erythema was performed by the use of an optical densitometer allowing to quantify, on a logarithmic scale, total reflected optical density (visual=V) and the values of primary subtractive colours of reflected light: cyan(=C), magenta(=M) and yellow(=Y). Calculation of erythema index was done as follows: E.I.=logRmagenta-logRcyan

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026